skip to main |
skip to sidebar
More details on that Genentech cut
In a move away from a "national strategy" in favor of localized operations, Genentech is planning to part ways with hundreds of staffers over the next few months.
The U.S. unit of Swiss drug giant Roche, Genentech is cutting 474 jobs, according to a notice filed with the state of California. While many of the cuts are in clinical operations, the San Francisco Chronicle reports that 44 division managers and 32 territory managers will be affected by the layoffs. Many of the cuts take effect in mid-September, but some employees will depart in August and some in October, according to the report.
A spokeswoman told Fierce Pharma the company this year "launched a new customer-engagement approach that will transform the way we serve patients, physicians, providers, payors and pharmacies across the country."
Best wishes to them.
I got to know the clin ops people at my last job, and was surprised to find out how extensively that field is covered by temp agencies and how readily individuals move from company to company (and at least sometimes from contract to full employee). The result is a surprisingly tight network, especially in hubs like northern NJ.
ReplyDeleteThat doesn't mean abrupt transitions like this don't suck, and I feel for the former employees, but at least some of the odds are in their favor.